Literature DB >> 34128049

High anaphylaxis rates following vaccination with the Pfizer BNT162b2 mRNA vaccine against COVID-19 in Japanese health care workers; a secondary analysis of initial post-approval safety data.

Takanao Hashimoto1, Akihiko Ozaki2, Divya Bhandari3, Toyoaki Sawano4, Ranjit Sah5, Tetsuya Tanimoto6.   

Abstract

Entities:  

Keywords:  BNT162b2 mRNA Covid-19 Vaccine; Japan; anaphylaxis; safety

Year:  2021        PMID： 34128049     DOI： 10.1093/jtm/taab090

Source DB:  PubMed          Journal:  J Travel Med        ISSN： 1195-1982            Impact factor:   8.490


× No keyword cloud information.
  6 in total

Review 1.  Management of BNT162b2 mRNA COVID-19 vaccine in children aged 5-11 years with allergies, asthma, and immunodeficiency: consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP).

Authors:  Elio Novembre; Mariangela Tosca; Carlo Caffarelli; Mauro Calvani; Fabio Cardinale; Riccardo Castagnoli; Elena Chiappini; Claudio Cravidi; Michele Miraglia Del Giudice; Marzia Duse; Amelia Licari; Sara Manti; Alberto Martelli; Giampaolo Ricci; Giuseppe Pingitore; Gian Luigi Marseglia
Journal:  Ital J Pediatr       Date:  2022-05-16       Impact factor: 3.288

2.  The risk of anaphylaxis behind authorized COVID-19 vaccines: a meta-analysis.

Authors:  Marharyta Sobczak; Rafał Pawliczak
Journal:  Clin Mol Allergy       Date:  2022-01-17

3.  A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions: complement activation as a possible contributing factor.

Authors:  Tamás Radovits; János Szebeni; László Dézsi; Tamás Mészáros; Gergely Kozma; Mária H-Velkei; Csaba Zs Oláh; Miklós Szabó; Zsófia Patkó; Tamás Fülöp; Mark Hennies; Miklós Szebeni; Bálint András Barta; Béla Merkely
Journal:  Geroscience       Date:  2022-02-11       Impact factor: 7.581

4.  Clinical and Molecular Characterization of a Rare Case of BNT162b2 mRNA COVID-19 Vaccine-Associated Myositis.

Authors:  Eli Magen; Sumit Mukherjee; Mahua Bhattacharya; Rajesh Detroja; Eugene Merzon; Idan Blum; Alejandro Livoff; Mark Shlapobersky; Gideon Baum; Ran Talisman; Evgenia Cherniavsky; Amir Dori; Milana Frenkel-Morgenstern
Journal:  Vaccines (Basel)       Date:  2022-07-16

Review 5.  A systemic review and recommendation for an autopsy approach to death followed the COVID 19 vaccination.

Authors:  Lii Jye Tan; Cai Ping Koh; Shau Kong Lai; Woon Cheng Poh; Mohammad Shafie Othman; Huzlinda Hussin
Journal:  Forensic Sci Int       Date:  2022-09-20       Impact factor: 2.676

Review 6.  Advances in COVID-19 mRNA vaccine development.

Authors:  Enyue Fang; Xiaohui Liu; Miao Li; Zelun Zhang; Lifang Song; Baiyu Zhu; Xiaohong Wu; Jingjing Liu; Danhua Zhao; Yuhua Li
Journal:  Signal Transduct Target Ther       Date:  2022-03-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.